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ABSTRACT
Objectives: We aimed to create a ‘multidatabase’
algorithm for identification of cholestatic liver injury
using multiple linked UK databases, before (1)
assessing the improvement in case ascertainment
compared to using a single database and (2)
developing a new single-database case-definition
algorithm, validated against the multidatabase
algorithm.
Design: Method development for case ascertainment.
Setting: Three UK population-based electronic health
record databases: the UK Clinical Practice Research
Datalink (CPRD), the UK Hospital Episodes Statistics
(HES) database and the UK Office of National Statistics
(ONS) mortality database.
Participants: 16 040 people over the age of 18 years
with linked CPRD–HES records indicating potential
cholestatic liver injury between 1 January 2000 and 1
January 2013.
Primary outcome measures: (1) The number of
cases of cholestatic liver injury detected by the
multidatabase algorithm. (2) The relative contribution
of each data source to multidatabase case status. (3)
The ability of the new single-database algorithm to
discriminate multidatabase algorithm case status.
Results: Within the multidatabase case identification
algorithm, 4033 of 16 040 potential cases (25%) were
identified as definite cases based on CPRD data. HES
data allowed possible cases to be discriminated from
unlikely cases (947 of 16 040, 6%), but only facilitated
identification of 1 definite case. ONS data did not
contribute to case definition. The new single-database
(CPRD-only) algorithm had a very good ability to
discriminate multidatabase case status (area under the
receiver operator characteristic curve 0.95).
Conclusions: CPRD–HES–ONS linkage confers
minimal improvement in cholestatic liver injury case
ascertainment compared to using CPRD data alone,
and a multidatabase algorithm provides little additional
information for validation of a CPRD-only algorithm.
The availability of laboratory test results within CPRD
but not HES means that algorithms based on CPRD–
HES-linked data may not always be merited for studies
of liver injury, or for other outcomes relying primarily
on laboratory test results.
BACKGROUND
Electronic health records stored within very
large population-based primary and second-
ary care databases are an increasingly import-
ant research resource internationally. These
are longitudinal records, capturing informa-
tion generated as part of routine clinical
care.1 A record for an individual patient will
include anonymised information on demo-
graphics, diagnoses, prescriptions and refer-
rals. Epidemiological studies within these
databases may apply case-identiﬁcation algo-
rithms to identify disease cases that may have
occurred months or years previously, for
inclusion in (historical) cohort or case–
control analyses.2–4 An alternative approach
involves active case detection, continuously
screening the databases so that cases may be
selected for inclusion in analysis as they arise
in the source population.5
Critical for epidemiological studies and
active case detection is the ability to accur-
ately identify outcomes. This is often challen-
ging within these databases, where the
information has been entered as part of
routine clinical care, and not for the
purpose of a speciﬁc study. Outcome
Strengths and limitations of this study
▪ Development of a new clearly defined and repro-
ducible algorithm for the detection of liver injury
using linked UK electronic health record
databases.
▪ Development of a primary care algorithm capita-
lising on the strength of the linked data algo-
rithm but usable on any group of primary care
patients, irrespective of linkage status.
▪ A lack of accessible laboratory test result data in
UK secondary care electronic health records
limits the added value of UK secondary care data
for detecting liver injury.
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deﬁnitions can therefore only be based on the informa-
tion recorded as part of this care, which may be non-
speciﬁc, and/or challenging to distinguish from all the
other healthcare information recorded for that patient.
Furthermore, individual databases cover a single care
setting (eg, primary or secondary care), meaning that
ascertainment of case status may be based on data that
are only a partial description of overall healthcare.
In recent years, data linkages have been created
between databases. This provides the potential to
perform case ascertainment using a richer and more
detailed set of data than in a single database, as informa-
tion from multiple healthcare settings can be combined.
To ensure that analyses do not have to be limited only to
the subset of patients who have records present in each
of the linked databases (reducing power for epidemio-
logical studies and making active case detection very
slow), there is the potential to use an algorithm devel-
oped using data from multiple linked databases to valid-
ate a single-database algorithm. This single-database
algorithm could then be applied to the entire popula-
tion of that database, irrespective of linkage status.
In this study, we focused on cholestatic liver injury, a
subtype of serious liver injury and a common reason for
drug licence withdrawal.6 7 Our main aim was to test
whether a multidatabase cholestatic liver injury case-
identiﬁcation algorithm that used linked UK databases
would allow improved case ascertainment, compared to
using an unlinked primary care database. A secondary
aim was then to use the multidatabase algorithm to val-
idate a new single-database primary care algorithm that
capitalised on the strength of the linked data but could
be used on any patient within the primary care database,
irrespective of whether the individual had records
linked to other databases or not.
METHODS
Study aim
The primary aim was to assess whether a ‘multidatabase’
cholestatic liver injury case-identiﬁcation algorithm that
used linked UK databases would allow improved case
ascertainment, compared to using an unlinked primary
care database. A secondary aim was then to use the multi-
database algorithm to validate a new Clinical Practice
Research Datalink (CPRD)-only algorithm that capitalised
on the strength of the linked data but could be used on
any patient within the CPRD database, irrespective of
whether they had records linked to other databases or not.
Setting/data sources
Three linked UK databases were used in this study: the
primary care CPRD, the secondary care Hospital Episodes
Statistics (HES) database and the Ofﬁce of National
Statistics (ONS) mortality database.8 Data were extracted
covering the dates of 1 January 2000 to 1 January 2013.
Further information is provided in the online
supplementary material, 1. Description of data sources.
Outcome
The outcome was cholestatic liver injury, characterised
by symptoms, including jaundice, a distinct pattern of
liver test results and hospital procedure results.9
Cholestatic liver injury has the potential to be well ascer-
tained by using a combination of primary and secondary
care data, as an individual’s care is likely to include
symptoms, tests, procedures and diagnoses performed
across care settings.
Algorithm development
Two algorithms were developed for the identiﬁcation of
cholestatic liver injury; one multidatabase algorithm
using CPRD, HES and ONS data and a second CPRD-
only algorithm using data only from within the CPRD
database (validated against the multidatabase algorithm).
Multidatabase cholestatic liver injury algorithm
development
Multidatabase algorithm development was facilitated by
reviewing studies selected by a systematic literature
search as detailed in the online supplementary material,
2. Literature search for multidatabase algorithm devel-
opment,2 4 10–19 along with a recent study on ascertain-
ment of liver injury in two primary care databases3 and a
paper describing an international consensus meeting on
drug-induced liver injury.9 Diagnostic terms, codelists
and laboratory parameters were selected based on a
review of all these papers, with ﬁnal terms and overall
algorithm design reviewed by a member of the study
team who is a general practitioner and professor in clin-
ical epidemiology (LS). Figure 1 provides an overview of
the design of the multidatabase cholestatic liver injury
algorithm, detailing the steps performed in order to
assign a cholestatic liver injury case status.
Selection of participants from CPRD (primary care) records
based on liver diagnostic codes
A list of clinical diagnostic Read codes that could repre-
sent cholestatic liver injury was prepared using the
search terms detailed in the online supplementary
material. These were separated into three groups accord-
ing to strength of evidence for liver injury, with group 1
including only the term ‘toxic liver disease with cholesta-
sis’, group 2 consisting of jaundice-related terms and
group 3 including other less speciﬁc liver pathology
terms (see online supplementary material, 3. Diagnostic
terms indicating liver injury for the full list of terms/
codes and their grouping, also uploaded to the public
ClinicalCodes.org repository20). The CPRD database was
searched for individuals over the age of 18 years with a
ﬁrst occurrence of any of the liver-related terms between
1 January 2000 and 31 January 2013 who had at least
12 months follow-up prior to their index (diagnosis)
date (in order to ensure the reliability of any diagnoses).
Any individuals from practices that were not linked to
HES were then removed (ie, practices in Scotland or
Wales).
2 Wing K, et al. BMJ Open 2016;6:e012102. doi:10.1136/bmjopen-2016-012102
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Management of CPRD liver test data
All CPRD test results for bilirubin, alkaline phosphatase
(ALP) and alanine aminotransferase (ALT) were
selected for the cohort. Blood levels of these enzymes
are standard parameters for indicating and classifying
serious liver injury based on the R value (=the ratio of
(ALT/ULN)/(ALP/ULN), where the ULN is the upper
limit of the normal blood level for the enzyme).9 Details
of the classiﬁcation and data management/cleaning per-
formed to obtain R values are provided in the online
supplementary material, 4. Classiﬁcation and data man-
agement of test results. Following classiﬁcation, any
results >90 days from the index diagnosis date were then
removed.
Figure 1 Overview of steps performed by the multidatabase cholestatic liver injury algorithm. CPRD, Clinical Practice Research
Datalink; HES, Hospital Episodes Statistics; ONS, Office of National Statistics.
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Selection of HES diagnoses and procedures and ONS
mortality data
The same search terms used previously were used to
search the HES diagnostic terms (coded according to
ICD-10). Hospital diagnoses were considered to be more
accurate than primary care diagnoses, due to specialised
clinical care and the availability of additional proce-
dures, so only two relatively speciﬁc terms were selected:
‘toxic liver disease with cholestasis’ (group 1) and
‘unspeciﬁed jaundice’ (group 2) (see online
supplementary material, 3. Diagnostic terms indicating
liver injury). Liver-related procedures (such as a biopsy
or a scan) can support the classiﬁcation of the type of
liver injury,9 and a list of relevant procedure terms was
prepared (see online supplementary material, 5. HES
procedure terms). HES hospital diagnosis data for the
cohort were then searched for (1) any liver-related diag-
nosis within 1 year before or after the CPRD index date
and (2) any liver-related procedure performed during
the same hospitalisation as any liver-related diagnosis.
Figure 2 provides an overview of all the data sources
and time periods searched in obtaining data for a multi-
database algorithm cholestatic liver injury health record.
Multidatabase algorithm status assignment
The multidatabase cholestatic liver injury algorithm case
status was then assigned based on the presence or
absence of data from each of the databases. Anyone with
a CPRD cholestatic liver test result was considered to be
a ‘deﬁnite’ case, based on internationally agreed consen-
sus of the importance of biochemical criteria.9 21
Individuals who had died and had an ONS ICD code
that indicated a death certiﬁcate coded with ‘toxic liver
disease with cholestasis’ (group 1) were also considered
to be deﬁnite cases, in addition to individuals who were
assigned this code in hospital after a biopsy or scan.
Subsequent case statuses (from very likely through prob-
able, possible, least likely and non-case) were then
assigned as detailed in table 1.
CPRD cholestatic liver injury algorithm development
Selection of participants and setup of explanatory/response
variables
The CPRD database was searched for individuals over
the age of 18 years with a ﬁrst occurrence of any of the
liver-related codes between 1 January 2000 and 31
January 2013 who had at least 12 months follow-up prior
to their index diagnosis date (index date), to ensure
that only incident cases were assessed. Binary variables
(0, 1) were then created for each potential explanatory
variable. Four main characteristics were considered a
priori to be potential predictors of the multidatabase
algorithm cholestatic liver injury case status: liver test
result information, hospital referral information around
the index date, the type of liver-related index diagnosis
and information on any other liver-related diagnosis
apart from the index diagnosis. A full list of the poten-
tial explanatory variables considered is provided in the
Figure 2 Data sources and time periods searched in obtaining data for a multidatabase algorithm cholestatic liver injury health
record. CPRD, Clinical Practice Research Datalink; HES, Hospital Episodes Statistics; ONS, Office of National Statistics.
4 Wing K, et al. BMJ Open 2016;6:e012102. doi:10.1136/bmjopen-2016-012102
Open Access
group.bmj.com on October 5, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
online supplementary material, 6. List of CPRD algo-
rithm explanatory variables. The outcome (response
variable) was the multidatabase case status, categorised
so that a value of 1 was a multidatabase case status of
deﬁnite through to possible, while 0 was a multidatabase
case status of least likely or non-case.
Statistical analysis
The cohort was randomly split into two separate data
sets of equal size, one for statistical model building (the
training data set) and the other for testing of the model
(the validation data set).
Using the training data set, the potential CPRD
explanatory variables were tabulated against case status.
CPRD explanatory variables that perfectly predicted
multidatabase deﬁnite-possible case status (ie, 100% of
the individuals in one of the binary categories of the
potential explanatory variable were cases) were removed
from subsequent univariable and multivariable analysis,
as were any variables with zero individuals within any cat-
egory. Univariable analysis was then performed.
In multivariable analysis, Firth’s logistic regression
methodology was used, which can handle strata with
sparse data by using penalised maximum likelihood esti-
mation.22 An initial multivariable logistic regression
model was ﬁtted that included all potential CPRD
explanatory variables. A ﬁnal CPRD algorithm model
was then prepared by removing variables with p>0.05
from the fully adjusted model in a stepwise fashion, in
order of increasing strength of evidence for association.
Likelihood ratio tests were used to obtain p values.
STATA (V.14.1) was used for all statistical analysis.
CPRD algorithm score generation and assignment
Variables for storing explanatory variable ‘scores’ were
added to the validation data set, and if an individual
had a value of 1 for any of the CPRD explanatory vari-
ables, the corresponding score variable was populated
with the multivariable regression analysis log odds value.
Those individuals who had a ‘1’ for any of the variables
shown to be perfect predictors of multidatabase case
status were assigned a ‘perfect prediction’ CPRD algo-
rithm score (a score that was manually inputted as
higher than the highest combined possible explanatory
variable score). A total score variable was created to hold
the total score for an individual, based on the presence
of CPRD explanatory variables.
Receiver operator characteristic analysis of CPRD cholestatic
liver injury algorithm and consideration of cut-off scores
The ability of the CPRD cholestatic liver injury algorithm
to discriminate between the two multidatabase cases sta-
tuses (deﬁnite to possible vs least likely to non-) was
assessed by plotting a receiver operator characteristic
Table 1 Assignment of the multidatabase algorithm case status using CPRD, HES and ONS data
Serial
number
CPRD (Read)
diagnostic
code
HES diagnostic (ICD-10) code (plus HES procedural code
and ONS mortality code, where considered)
CPRD liver
test
result
Multidatabase
algorithm
case status
1. Group 1|2|3* Not considered Cholestatic Definite
2. Group 1|2|3 ONS (death): group 1 Not considered Definite
3. Group 1|2|3 Biopsy/scan+group 1 Not considered Definite
4. Group 1 Group 1 None† Very likely
5. Group 1 Group 2 or no HES record‡ None Probable
6. Group 2|3 Group 1 None Probable
7. Group 1 Group 1|2 Not cholestatic§ Possible
8. Group 1 HES record has no codes of interest¶ None Possible
9. Group 2 Group 1 Not cholestatic Possible
10. Group 2 Group 2 None Possible
11. Group 1 No HES record|HES record has no codes of interest Not cholestatic Least likely
12. Group 2 No HES record|HES record has no codes of interest None Least likely
13. Group 3 Group 1 Not cholestatic Least likely
14. Group 2 Group 2|no HES record|HES record has no codes of interest Not cholestatic Non-case
15. Group 3 Group 2 None|not
cholestatic
Non-case
16. Group 3 No HES record None|not
cholestatic
Non-case
17. Group 3 HES record has no codes of interest None|not
cholestatic
Non-case
*Group 1: toxic liver disease with cholestasis, group 2: jaundice-related codes and group 3: other less specific liver injury codes (see online
supplementary data, 3. Diagnostic terms indicating liver injury for full lists of terms).
†No liver test result recorded within 90 days of index diagnosis.
‡No HES record indicates person did not attend hospital <1 year either side of index diagnosis.
§Liver test result was recorded <90 days from index diagnosis, but results indicate either no injury or pure hepatic injury.
¶Person attended hospital <1 year from index diagnosis but no liver diagnoses of interest.
CPRD, Clinical Practice Research Datalink; HES, Hospital Episodes Statistics; ONS, Office of National Statistics.
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(ROC) graph (sensitivity vs 1−speciﬁcity) across the
range of CPRD algorithm scores.
RESULTS
Participants
Between 1 January 2000 and 1 January 2013, 37 520
people were identiﬁed in CPRD with codes indicative of
possible liver injury. Seven thousand and ﬁfty-six people
were removed as they were ineligible (see ﬁgure 3), and
removal of a further 14 424 individuals from practices
not linked to HES left a total of 16 040 individuals in the
multidatabase algorithm cohort. Dividing this randomly
into two data sets left 8020 people in the CPRD-only
algorithm training and validation cohorts.
Multidatabase algorithm development
Descriptive data
The median age of the cohort was 62 years, and 52%
were men (table 2). There was a slight increase in the
number of diagnoses for the codes of interests over the
recruitment period of 2000–2012 (with 30% of codes
diagnosed between 2009 and 2012), but only in accord-
ance with the increase in size of the database between
2009 and 2012 (see online supplementary data, 7.
Increase in size of CPRD database from 2000 onwards).
The most common CPRD index diagnoses codes were
jaundice, obstructive jaundice and cholangitis. Over 54%
of people had a CPRD liver test result recorded within
90 days of their index diagnosis date. Seventy-nine per
cent of people had been admitted to hospital for any
reason within 1 year either side of the index diagnosis
date.
Figure 3 Flow of number of individuals included in the
multisource algorithm and the Clinical Practice Research
Datalink (CPRD) algorithm cohorts. *Ineligible: <18 years of
age or registered in CPRD for <12 months prior to liver-related
diagnosis. **No Hospital Episodes Statistics (HES) linkage:
individual was registered with a primary care practice that was
not part of the HES-linkage process (ie, practices in Scotland,
Wales or Northern Ireland; English practices that have not
agreed to participate and patients within participating practices
that have opted out).
Table 2 Characteristics of people (N=16 040) included
in the multidatabase algorithm cohort (data from CPRD
record unless otherwise stated)
n (%)
Age at index diagnosis date*
18–29 948 (6)
30–39 1452 (9)
40–49 2164 (13)
50–59 2736 (17)
60–69 2937 (18)
70–79 3127 (20)
80+ 2676 (17)
Median (25–75%) 62 (47–75)
Gender
Male 8406 (52)
Female 7634 (48)
Date of index diagnosis
2000–2002 3336 (21)
2003–2005 3867 (24)
2006–2008 3962 (25)
2009–2012 4875 (30)
Index diagnosis
Jaundice† 6951 (43)
Obstructive jaundice 2531 (16)
Cholangitis 1144 (7)
Hepatitis unspecified 408 (4)
Chronic hepatitis 541 (3)
Other liver disorders 528 (3)
Biopsy of liver 412 (3)
Any other code‡ 3223 (20)
Liver test results§
No liver test result 7354 (46)
Test results before index diagnosis 4039 (25)
Test results on or after index diagnosis 4647 (29)
HES record¶
No HES record 3392 (21)
HES record before index diagnosis 923 (6)
HES record on or after index diagnosis 11 725 (73)
ONS mortality record**
No ONS mortality record 10 157 (63)
Had ONS mortality record 5883 (37)
*Date of diagnosis with one of the potential cholestatic liver injury
codes listed in the online supplementary material.
†Includes codes ‘Jaundice—symptom’, ‘[d]jaundice’, ‘O/e—
jaundiced’, ‘[d]jaundice (not of newborn)’.
‡People in this group had an index diagnosis of any of the other
codes listed in the online supplementary material.
§No liver test results=none within 90 days either side of index
diagnosis date; test results before/after=closest liver test result
was before/after the index and within 90 days.
¶No HES record=no HES record ever (n=1080) or no record
within 365 days either side of index diagnosis date (n=2312); HES
record before/after index diagnosis=closest HES record was
before/after the index and within 365 days.
**ONS mortality record at any time (after index diagnosis).
CPRD, Clinical Practice Research Datalink; HES, Hospital
Episodes Statistics; ONS, Office of National Statistics.
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Results
Of 16 040 cohort, 4032 (25%) were assigned as deﬁnite
cases, with almost all of these assigned due to the pres-
ence of a cholestatic liver test result recorded in CPRD
(table 3). None of the individuals who had ONS mortal-
ity records had ‘toxic liver disease with cholestasis’ indi-
cated on their ONS death certiﬁcate, and after
assignment of deﬁnite cases based on CPRD liver test
results, HES procedure (eg, biopsy or scan) data only
allowed one further deﬁnite case to be assigned. Of
16 040 cohort, 977 (6%) were assigned as possible cases
of cholestatic liver injury, with the majority (947/977)
due to codes related to jaundice (group 2) in both data-
bases but a lack of liver test results. The remainder of
the cohort was assigned as unlikely or non-cases.
CPRD algorithm development
Univariable and multivariable analysis (training cohort)
Liver test result status was shown to perfectly predict
multidatabase case status, that is, all of those with CPRD
cholestatic liver test results were classiﬁed as cases, while
no individuals with an index diagnosis of cholaemia
were classiﬁed as cases. These variables were, therefore,
not considered for subsequent univariable or multivari-
able analysis. The univariable and multivariable results
for the CPRD variables included in the ﬁnal CPRD cho-
lestatic liver injury algorithm are provided in table 4,
while the univariable results for all of the potential
CPRD variables initially tested and the initial fully
adjusted model are provided in the online
supplementary material, 8. Results for all potential
CPRD explanatory variables. The two CPRD explanatory
variables that were the strongest predictors of being a
case were having an index diagnosis of ‘toxic liver
disease with cholestasis’ (multivariable OR 20.59, 95%
CI 9.41 to 45.08) or having an index diagnosis of
‘obstructive jaundice’ (multivariable OR 6.64, 95% CI
5.42 to 8.13) (table 4). Having a code for ‘jaundice’ (or
similar) was also strongly associated with being a case
(multivariable OR 5.10, 95% CI 4.25 to 6.11). People
who had any referral recorded in CPRD within 30 days
before or after the index diagnosis date were more likely
Table 3 Multisource cholestatic liver injury algorithm—results of case status assignment
CPRD (Read)
diagnostic
code
HES diagnostic (ICD-10) code (plus HES
procedural code or ONS mortality code,
where considered)
CPRD liver
test result
Multisource
algorithm
case status
(N=16 040)
n (%)
Group 1|2|3* Not considered Cholestatic Definite 4032 (25)
Group 1|2|3 ONS (mortality): group 1 Not considered Definite 0 (0)
Group 1|2|3 HES biopsy/scan+group 1 Not considered Definite 1 (0)
Total definite 4033 (25)
Group 1 Group 1 None† Very likely 0 (0)
Total very
likely
0 (0)
Group 1 Group 2 or no HES record‡ None Probable 0 (0)
Group 2|3 Group 1 None Probable 4 (0)
Total probable 4 (0)
Group 1 Group 1|2 Not cholestatic§ Possible 1 (0)
Group 1 HES no codes of interest¶ None Possible 25 (0)
Group 2 Group 1 Not cholestatic Possible 4 (0)
Group 2 Group 2 None Possible 947 (6)
Total possible 977 (6)
Group 1 No HES record|
HES no codes of interest
Not cholestatic Unlikely 22 (0)
Group 2 No HES record|
HES no codes of interest
None Unlikely 3468 (22)
Group 3 Group 1 Not cholestatic Unlikely 2 (0)
Total unlikely 3492 (22)
Group 2 Group 2|no HES record|
HES no codes of interest
Not cholestatic Non-case 2869 (18)
Group 3 Group 2 None|not cholestatic Non-case 173 (1)
Group 3 No HES record None|not cholestatic Non-case 340 (2)
Group 3 HES no codes of interest None|not cholestatic Non-case 4152 (26)
Total non-case 7534 (47)
*Group 1=highest evidence for cholestatic liver injury and group 3=lowest evidence.
†No liver test result recorded within 90 days of index diagnosis.
‡No HES record indicates that person did not attend hospital <1 year either side of index diagnosis.
§Liver test result was recorded <90 days from index diagnosis, but results indicate either no injury or pure hepatic injury.
¶Person attended hospital <1 year from index diagnosis but no liver diagnoses of interest.
CPRD, Clinical Practice Research Datalink; HES, Hospital Episodes Statistics.
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to be cases (multivariable OR 1.48, 95% CI 1.33 to
1.65), as were people referred for a liver-related scan or
test (multivariable OR 1.51, 95% CI 1.18 to 1.94).
Having an additional liver-related diagnosis within
30 days of the index diagnosis date was also a weak pre-
dictor for being a case (multivariable OR 1.49, 95% CI
1.33 to 1.67).
ROC analyses of cholestatic liver injury algorithm and
consideration of cut-off scores (validation cohort)
After adding the variables shown to be predictors of
multidatabase algorithm case status in the training
cohort to the validation cohort and generating a CPRD
algorithm score for each person, the sensitivity and spe-
ciﬁcity of the algorithm was assessed by applying the
algorithm to the validation cohort data, using a range of
cut-off scores to deﬁne case status. A ROC of these
results is provided in ﬁgure 4, with the full tabulation of
results provided in the online supplementary material,
9. Tabulation of ROC results.
Area under ROC curve: 0.95
The area under the curve (AUC) value of 0.95 obtained
indicates that overall the complete CPRD algorithm has
an excellent ability to discriminate between individuals
with a multidatabase algorithm case status of ‘deﬁnite’
to ‘possible’ and individuals with a multidatabase algo-
rithm case status of ‘unlikely’ to ‘non-’. Tabulation of
ROC results provides detail on how the sensitivity and
speciﬁcity is related to the total CPRD algorithm (stage
Table 4 Descriptive, univariable and multivariable analysis of the association between being a multidatabase algorithm
(definite to possible) case and the CPRD explanatory variables included in the final CPRD algorithm
CPRD explanatory
variable
Total (N=8020),
n (%)
Cases (N=2470),
n (%)
Crude OR
(95% CI)
Multivariable*
OR (95% CI) p Value†
CPRD liver test result
None|not cholestatic 6044 (75) 494 (8) – –
Cholestatic 1976 (25) 1976 (100) – –
Had any referrals‡
None 4650 (58) 1132 (24) 1 1
One or more referrals 3370 (42) 1338 (40) 2.04 (1.86 to 2.25) 1.48 (1.33 to 1.65) <0.001
Jaundice (or similar) index diagnosis
No 4301 (54) 944 (22) 1 1
Yes 3719 (46) 1526 (41) 2.47 (2.24 to 2.73) 5.10 (4.25 to 6.11) <0.001
Cholangitis-related index diagnosis
No 7262 (91) 2337 (33) 1 1
Yes 758 (9) 133 (18) 0.45 (0.37 to 0.54) 1.89 (1.47 to 2.44) <0.001
Chronic hepatitis index diagnosis
No 7720 (96) 2464 (32) 1 1
Yes 300 (4) 6 (2) 0.04 (0.02 to 0.10) 0.20 (0.09 to 0.45) <0.001
Obstructive jaundice index diagnosis
No 6774 (84) 1886 (28) 1 1
Yes 1246 (16) 584 (47) 2.29 (2.02 to 2.59) 6.64 (5.42 to 8.13) <0.001
Toxic liver with cholestasis index diagnosis
No 7989 (99) 2448 (31) 1 1
Yes 31 (1) 22 (70) 5.53 (2.54 to 12.03) 20.59 (9.41 to 45.08) <0.001
Liver-enlargement-related index diagnosis
No 7939 (99) 2454 (31) 1 1
Yes 81 (1) 16 (20) 0.55 (0.32 to 0.95) 1.98 (1.12 to 3.49) 0.027
Non-specific liver-related index diagnosis
No 7598 (95) 2439 (32) 1 1
Yes 422 (5) 29 (7) 0.16 (0.11 to 0.23) 0.63 (0.42 to 0.95) 0.020
Number of additional liver-related diagnoses‡
None 6165 (77) 1652 (27) 1 1
One|more 1855 (23) 818 (44) 2.15 (1.94 to 2.40) 1.49 (1.33 to 1.67) <0.001
Referral for liver-related scan|test‡
No referral 7719 (96) 2312 (30) 1 1
Had a referral 301 (4) 158 (53) 2.58 (2.05 to 3.26) 1.51 (1.18 to 1.94) <0.001
*Multivariable OR: Frith method (see Chapter 3), adjusted for all other variables in this table. Variables were selected for inclusion in the final
multivariable model by initially preparing a fully adjusted model (see online supplementary table S8), and removing those variables with
p>0.05 using a backwards stepwise approach.
†p value: result of the likelihood ratio test of the association of the variable with the outcome after adjustments for all other variables in the
table.
‡Multiple variables: ±30 days from index.
CPRD, Clinical Practice Research Datalink; index, index diagnosis.
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1 and stage 2 case assignment) score; this shows that
with increasing speciﬁcity, sensitivity remains high (for a
speciﬁcity of 100.0%, sensitivity is over 80.0%).
DISCUSSION
In this study, we have compared the performance of
primary care and multidatabase (primary, secondary
and mortality) algorithms to identify cases of cholestatic
liver injury and found that minimal additional informa-
tion for case detection is provided by secondary care
and mortality databases.
Multidatabase algorithm
The results for the development of the multidatabase
algorithm showed that deﬁnite case status is heavily
inﬂuenced by the CPRD record, with almost all of the
deﬁnite cases assigned as such based on liver enzyme
level test results recorded in CPRD. ONS information
did not facilitate the identiﬁcation of additional deﬁnite
cases, while HES data only allowed for the identiﬁcation
of one additional deﬁnite case.
Around half of the cohort did not have a liver test
result recorded in CPRD within 90 days either side of
their index diagnosis. Given that the cohort participants
were selected by the presence of liver-related diagnostic
codes, one could expect that standard clinical procedure
would be to have performed a test of liver enzyme levels
within the period of 90 days before or after the index
diagnosis. Many of the individuals who did not have liver
tests recorded in primary care (CPRD) are, therefore,
likely to have had tests performed and recorded in sec-
ondary care. An important limiting factor of HES data is
that while liver enzyme level tests are performed in UK
hospitals, results are not included in the HES database.
If results from hospital liver tests were available in HES,
this could result in many individuals within the cohort
being promoted from possible, unlikely or non-case
status to ‘deﬁnite’.
The HES data in this algorithm did allow possible
cases to be distinguished from unlikely cases, within
people who had a code for ‘jaundice’ in CPRD but did
not have any liver test results recorded. These people
make up 28% of the cohort, with around a ﬁfth of these
people (6% of the cohort) identiﬁed as possible cases
(rather than unlikely cases) due to the presence of a
code for ‘jaundice’ in the HES data.
The lack of any information obtained from the ONS
mortality data for the algorithm is likely to be due to the
rarity of toxic liver disease with cholestasis as a cause of
death.
CPRD algorithm
A liver enzyme test result of cholestatic was a perfect pre-
dictor of multidatabase case status. Strong predictors
were diagnostic terms that clinically would be expected
to be describing a cholestatic type of liver injury (toxic
liver disease with cholestasis, obstructive jaundice and
jaundice). Having other referrals was also associated
with being a multidatabase case.
The ROC analysis showed that the CPRD algorithm
had very good ability to discriminate between the two
multidatabase algorithm case statuses. This is not an
unexpected result, given that the CPRD liver test results
were a strong driver of the multidatabase case status
(81% of the deﬁnite to possible multidatabase cases
have a cholestatic liver test result in CPRD). The result
does illustrate that an algorithm for identifying chole-
static liver injury that uses CPRD data alone can
perform almost as well as one that uses multiple data-
base sources.
Implications/context
Our key ﬁnding was that for studies of cholestatic liver
injury, if using linked CPRD–HES–ONS data, it is the
CPRD primary care data that facilitate almost all of the
‘deﬁnite’ case status assignment. It should be noted that
highly effective case-detection algorithms using data from
multiple linked sources have been developed within
other disease areas, for example, for vascular disease and
cancer.23 24 However, the lack of laboratory test result
data is a notable deﬁciency of HES data that limits the
added value of data linkages when working with out-
comes that rely predominantly on laboratory test result
data, such as cholestatic (or any type of) liver injury.
Our results do show that UK primary care (CPRD)
data on its own can be used effectively for studying
liver injury (and possibly other outcomes that rely on
laboratory test result data). The nature of HES data
meant that our goal of developing a CPRD algorithm
that capitalised on the strength of linked data was
somewhat limited. However, we believe that the
approach that we have used in the development of a
probabilistic algorithm could be of use to other
Figure 4 Receiver operating characteristics (ROC) graph of
sensitivity against 1−specificity for a range of Clinical Practice
Research Datalink (CPRD) algorithm cut-off scores,
comparing the CPRD cholestatic liver injury algorithm against
a multidatabase algorithm case status of probable to definite.
AUC=0.95.
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researchers, particularly if validated against a superior
‘gold standard’ (such as detailed records from a specialist
liver clinic). We have performed a thorough search of the
literature in order to identify diagnoses and liver test cri-
teria that informed our algorithm, and provided very
clear descriptions of and/or references to these (includ-
ing an internationally agreed standard for liver test cri-
teria). We also clearly deﬁned the time windows and data
management applied for detecting the injury within
CPRD. Performing a ROC analysis allowed the sensitivity
and speciﬁcity of a range of algorithm scores to be pre-
sented, and case deﬁnitions corresponding to speciﬁc
score cut-offs could be selected for deﬁning cases based
on different scenarios. For example, in pharmacoepide-
miology, the sensitivity and speciﬁcity of the score used to
identify people is likely to depend on the type of study
being performed, ﬁnancial resources available, time that
the drug has been on the market and frequency of liver
injury events associated with the drug.
Finally, an important consideration that should be
applied to studies of the incidence of liver injury in
CPRD (whether using just CPRD or HES-linked data) is
that if one relies on laboratory test results to deﬁne a
case, the estimated incidence is likely to be lower than
the true population incidence, due to the group of
people who have liver test results performed in second-
ary care but not primary care (the results of which are
not currently accessible from any population-level
database).
Limitations
In the development of the CPRD algorithm, the
response variable ‘case’ included multidatabase case sta-
tuses of ‘deﬁnite’ to ‘possible’. There is, therefore, a
potential for people to have been incorrectly classiﬁed
as cases of cholestatic liver injury in this scenario, and
the development of a CPRD algorithm based on this
potentially non-speciﬁc case deﬁnition could lead to the
identiﬁcation of false-positive cases. Including these
people in the response variable ‘case’ was considered
preferable to not including them, however, because it is
likely that many of them did have liver tests performed
in hospital that indicated cholestasis, but this informa-
tion was not available within the HES database.
CONCLUSIONS
In this article, we have attempted to capitalise on lin-
kages between UK primary and secondary care databases
in order to optimise methods for the detection of cases
of cholestatic liver injury. An a priori assumption was
that an algorithm that used combined information from
multiple care settings (ie, including primary care data
from CPRD, secondary care data from HES and ONS
mortality data) would allow more accurate case identiﬁ-
cation than using primary care alone, and that this
could facilitate the development of an optimised
primary care algorithm. In fact, combined primary–
secondary–mortality data did not strengthen liver injury
case ascertainment when compared to the use of
primary care data alone.
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